CBA 2017 Annual Conference

HO Family Scholarship (CBA) is available thanks to the generosity of Ho family. Details and Application form here.

2017 Annual Conference Content


CBA 2017 Annual Conference registration open
(Online registration closed):
CBA Members:
$30 online (closed). Lunch included.
$40 onsite. Lunch not guaranteed.
Non-Members:
$50 online (closed). Lunch included.
$60 onsite. Lunch not guaranteed.


2017 CBA Annual Conference Current Agenda

Date & Time: Oct. 14, 2017 (8:00am-4:30pm PDT)
Location: Crowne Plaza, Foster City, CA
Theme: Promoting Biosciences for Better Human Health- CBA 20th Anniversary

8:00-8:30 am Registration, Breakfast and Exhibitions
8:30 – 8:35 am Welcome and Opening Remarks
Patrick Yang, Ph.D., CBA president
8:35 – 8:40 am Conference Introduction
Huifang Li, Ph.D., CBA Conference Chair
Introduction: Lin Sun-Hoffman, Ph.D.
8:40 – 9:20 am Keynote Presentation: Innovative Drug Development: Maximizing Success and Value
Peony Yu, M.D. (CMO, Fibrogen Inc.)
Introduction: Mr. Caesar Ho
9:20 – 9:45 am Cepheid: from Rags to Riches
Kurt Petersen, Ph.D. (Co-Founder, Cepheid Inc.)

Panel Discussion I

Moderator: Mr. Caesar Ho & Mr. Ravi Mistry

9:45 – 10:25 am Entrepreneurship
Paul Hung, Ph.D. (CEO, COMBiNATi)
Ben Hwang (CEO, Profusa)
Dan Laser Ph.D. (CEO, Applaud Medical, Inc.)
Ben Wang, Ph.D. (Co-founder, Chimera Bioengineering)
Chandler Robinson, M.D. (CEO, Monopar Therapeutics)
10:25-10:40 am Networking and Exhibitions
10:40 – 11:05 am Build Scientist Town to Save Lives with Frontier Science and Technology
Mr. William Wei (VP of America Frontier Science Institute & Chief Architect of American Chinese Friendship Council)
11:05 – 11:30 am Opportunities for Biosimilar Companies under U.S. Legal System
Patricia Campbell, Ph.D. (Partner, Jones Day)
Bing Liang, Ph.D. (Associate Attorney, Jones Day)
11:30-11:45 am Sponsors speech
11:45-11:50 am Ho Family Scholarship
Mr. Caesar Ho
11:50 am – 12:00 pm CBA 20 years’ Review
Patrick Yang, Ph.D.
12:00-12:30 pm Lunch and Exhibitions
Introduction: Michelle Chen, Ph.D.
12:30 – 1:10 pm Keynote presentation: Avastin’s Development: The Case Study for Mega Brand
Philippe Bishop, M.D. (CMO, Aratinga.bio, Inc.)
1:10 – 1:35 pm Merck San Francisco: Commitment to Science-driven Transformational Medicines
James Mu, Ph.D. (Merck Research Laboratories San Francisco)
1:35 – 2:00 pm Transformation of BeiGene via Business Development and Partnership
Ji Li, Ph.D. (EVP, BeiGene)
2:00 – 2:15 pm Networking and Exhibitions

Panel Discussion II

Moderator: Michelle Chen, Ph.D.

2:15 – 2:55 pm Biotech Investment
Jennifer Hu, Ph.D. (Partner, Qiming US Healthcare Fund)
Alexi Ji, Ph.D./MBA (Partner, Illumina Ventures)
Rajeev Dadoo, Ph.D./MBA (Partner, SR One)
Vincent Xiang, Ph.D./MBA (Partner, Six Dimensions Capital)

Panel Discussion III

Moderator: Patty Kiang, Ph.D.

2:55 – 3:45 pm Biotech Supply Chain
Lee-Cheng Liu, Ph.D. (President & CEO, Eirgenix)
Ray Chen, Ph.D. (Sr. Director, Genscript)
Amit Chaudhuri, Ph.D. (VP, Medgenome)
Dan Zhang, Ph.D. (CEO, Fountain Medical Development)

Panel Discussion IV

Moderator: Lin Sun-Hoffman, Ph.D.

3:45 – 4:15 pm East West Convergence – One Mind, Two Coasts
4:15 – 4:25 pm Former CBA President Speech
Shian-Jiun Shih, Ph.D. (CBA founding President)
4:25 – 4:30 pm Closing Remarks
Huifang Li, Ph.D., CBA Conference Chair
4:30 – 7:00 pm Networking Reception